Statistical Issues in Drug Development, 3rd Edition, 9781119238577
Hardcover
Drug development’s statistical challenges revealed, fostering better communication and understanding.

Statistical Issues in Drug Development, 3rd Edition

$269.15

  • Hardcover

    640 pages

  • Release Date

    23 June 2021

Check Delivery Options

Summary

The revised third edition of Statistical Issues in Drug Development delivers an insightful treatment of the intersection between statistics and the life sciences. The book offers readers new discussions of crucial topics, including cluster randomization, historical controls, responder analysis, studies in children, post-hoc tests, estimands, publication bias, the replication crisis, and many more.

This work presents the major statistical issues in drug development in a way th…

Book Details

ISBN-13:9781119238577
ISBN-10:1119238579
Author:Stephen S. Senn
Publisher:John Wiley & Sons Inc
Imprint:John Wiley & Sons Inc
Format:Hardcover
Number of Pages:640
Edition:3rd
Release Date:23 June 2021
Weight:1.27kg
Dimensions:246mm x 178mm x 41mm
Series:Statistics in Practice
About The Author

Stephen S. Senn

Professor Stephen Senn (MSc, PhD, CStat) is a statistical consultant, researcher and blogger. He has extensive experience in both academia and industry, and is recognized worldwide for his studies in statistical methodology applied to drug development.

Professor Senn has been the recipient of national and international awards, including the 1st George C Challis award for Biostatistics at the University of Florida, and the Bradford Hill Medal of the Royal Statistical Society. He is a Fellow of the Royal Society of Edinburgh and an honorary life member of Statisticians in the Pharmaceutical Industry (PSI) and the International Society for Clinical Biostatistics (ISCB) and has honorary professorships in statistics at The University of Sheffield and the University of Edinburgh.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.